MCM
ABMD

Matarin Capital Management’s Abiomed Inc ABMD Stock Holding History

Matarin Capital Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-3,977
Closed -$285K – 209
2015
Q1 		$285K Buy
+3,977
New +$216K 0.09% 172

Other funds holding ABMD

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

Matarin Capital Management's ABMD Position: Q2 2015 in Review

Matarin Capital Management sold out of Abiomed Inc (ABMD) in Q2 2015, closing a stake of 3,977 shares — an estimated $285K sold.

Matarin Capital Management first reported a position in ABMD in Q1 2015 and held it in 1 quarter. The position peaked at $285K in Q1 2015. 227 funds tracked by Wall St. Rank hold ABMD as of Q2 2015.

  • Matarin Capital Management reported no remaining Abiomed Inc position as of Q2 2015 after selling out during the quarter.
  • Matarin Capital Management sold 3,977 Abiomed Inc shares in Q2 2015, an estimated $285K.
  • Matarin Capital Management first reported a position in Abiomed Inc in Q1 2015 and held it in 1 quarter.
  • Matarin Capital Management's Abiomed Inc position peaked at $285K in Q1 2015.
  • 227 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2015.

Based on Matarin Capital Management's 13F filing for Q2 2015, filed 13 Aug 2015.